Effects of Oral Semaglutide on Cardiovascular (and Other) Outcomes in People with Type 2 Diabetes at High CV Risk Sunday, June 22 at 4:30 - 6:00 PM CT About the ADA's Scientific Sessions The ADA's ...

A retrospective analysis published in the June 2025 issue of Clinical Research in Cardiology about obesity that had been prevalent in heart failure (HF), contributing to reduced QoL and increased ...

CHICAGO, June 21, 2025 /PRNewswire/ -- Today, a new analysis demonstrates the vascular benefits of semaglutide in patients with peripheral artery disease (PAD) and type 2 diabetes, including ...

GLP-1 drugs, such as semaglutide (sold under brand names like Ozempic and Wegovy), are a class of medications that mimic a hormone called glucagon-like peptide-1 (GLP-1).

Indeed, Saynor described that country as Novo's second-largest semaglutide market, and Ozempic sales in Canada garnered the pharma giant $2.5 billion CAD last year. "You gotta ask why.

The annual meeting will take place from June 20-23 in Chicago. The combination therapy of ECC4703 and semaglutide or tirzepatide resulted in significantly greater weight loss compared to semaglutide ...

A groundbreaking study led by researchers from Columbia Data Analytics, Bogazici University and the City University of New York (CUNY) College of Technology, has demonstrated that semaglutide, a ...

A groundbreaking study led by researchers from Columbia Data Analytics, Bogazici University and the City University of New York (CUNY) College of Technology, has demonstrated that semaglutide, a GLP-1 ...

Semaglutide — the active ingredient in Ozempic®, Wegovy®, and Rybelsus® — can reduce your appetite and curb food cravings to promote weight loss. But if you’re still hungry on semaglutide ...

The study included 7881 patients: 6109 and 1772 received semaglutide and tirzepatide, respectively; 80.8% had low maintenance dosages.